Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Phospholipid Modulator by Boehringer Ingelheim International for Unspecified Ophthalmological Disorders: Likelihood of Approval
Phospholipid Modulator is under clinical development by Boehringer Ingelheim International and currently in Phase I for Unspecified Ophthalmological Disorders. According...